Sonia Sein, outside her Bronx home, had irreparable damage to her trachea. She received a new trachea in January and is believed to be the first patient in the world to undergo a successful direct transplant of a donor trachea.Credit…Sarah Blesener for The New York Times SectionsSkip to contentSkip to site index ‘There Was Nothing… Read More: ‘There Was Nothing Anybody Could Do for These Patients.’ Now… »
FDA Approves Fotivda (tivozanib) for the Treatment of Adult Patients with Relapsed or Refractory Advanced Renal Cell Carcinoma BOSTON–(BUSINESS WIRE) March 10, 2021 — AVEO Oncology (Nasdaq: AVEO) today announced that the U.S. Food and Drug Administration (FDA) has approved Fotivda (tivozanib) for the treatment of adults with relapsed or refractory advanced renal cell carcinoma… Read More: FDA Approves Fotivda (tivozanib) for the Treatment of Adult Patients… »
TUESDAY, March 2, 2021 — When temperatures rise, people with multiple sclerosis need to keep cool. Heat sensitivity is a hallmark of the central nervous system disorder. So, what happens when warm weather spikes become more frequent because of climate change? More MS patients end up in the emergency room. A new study found that… Read More: How Climate Change Could Put More MS Patients in Danger »
FDA Approves Nulibry (fosdenopterin) to Reduce the Risk of Mortality in Patients with Molybdenum Cofactor Deficiency (MoCD) Type A PALO ALTO, February 28, 2021 – BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio) and affiliate Origin Biosciences, Inc. (Origin) today announced the U.S. Food and Drug Administration (FDA) has approved Nulibry (fosdenopterin) for Injection as the first… Read More: FDA Approves Nulibry (fosdenopterin) to Reduce the Risk of Mortality… »